Join us for an insightful webinar on the innovative uses of master protocols in clinical trials. The master protocol approach is transforming the landscape of drug development by allowing multiple treatments to be evaluated across different disease states or patient populations within a single trial structure. An approach like this can offer significant advantages, including increased efficiencies, faster decision-making and improved coordination but poses challenges to operationalization without the proper planning and support.

In this webinar, we will explore the key aspects of master protocols, discuss their benefits and challenges and provide practical insights into implementation and operationalization. Whether you are a researcher, clinician or part of the biopharma industry, this session will equip you with the knowledge to leverage master protocols effectively in your clinical research.

• Understand the benefits, optimal use cases and best scenarios for master protocols.
• Maximize trial operations with improved coordination and more sub-study opportunities.
• Enhance data collection and sharing, broadening patient access to new therapies.
• Navigate strategic relationships for safe and successful master protocol research.

Speakers:

Beth Chamblin, Senior Director, Project Management, Late Phase Oncology, IQVIA Biotech

Kelley Coalier, Associate Principal, Enterprise Transformation Strategy, IQVIA

Brad Smith, Vice President, Therapeutic Strategy, IQVIA

For more information and to register, click here.